7
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Pharmacological effects of dopaminergics and amantadine on color discrimination in Parkinson's disease

, , , &
Pages 135-141 | Accepted 16 Mar 1995, Published online: 08 Jul 2009

References

  • Bodis-Wollner I, Yahr M. Measurement of visual evoked potentials in Parkinson's disease. Brain 1978; 101: 661–671
  • Bodis-Wollner I, Marx M C, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987; 110: 1675–1698
  • Gawel M J, Das P, Vincent S, Clifford Rose F. Visual and auditory evoked responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiat 1981; 44: 227–232
  • Hutton J T, Morris J L, Elias J W, Varma R, Poston J N. Spatial contrast sensitivity is reduced in bilateral Parkinson's disease. Neurology 1991; 41: 1200–1202
  • Bodis-Wollner I, Tagliati M. The visual system in Parkinson's disease. Adv Neurol 1993; 60: 390–394
  • Bulens C, Meerwaldt J D, van der Wildt G J, van Deursen J B. Effect of levodopa treatment on contrast sensitivity in Parkinson's disease. Ann Neurol 1987; 22: 365–469
  • Hutton J T, Morris J L, Elias J W. Levodopa improves spatial contrast sensitivity in Parkinson's disease. Arch Neurol 1993; 50: 721–724
  • Sollazzo D. Influence of L-Dopa/ carbidopa on pattern reversal VEP: behavioural difference in primary and secondary parkinsonism. Electroen-cephalogr Clin Neurophysiol 1985; 61: 236–242
  • Büttner T H., Kuhn W, Klotz P, Steinberg R, Voss L, Bulgaru D, Przuntek H. Disturbance of colour perception in Parkinson's disease. J Neural Transm (PD-Sect.) 1993; 6: 11–15
  • Büttner T H, Patzold T, Kuhn W, Müller G H, Przuntek H. Impaired colour discrimination in Parkinson's disease. Neuro-Ophthalmology 1994; 14: 91–95
  • Price M J, Feldman R G, Adelberg D, Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992; 42: 887–890
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. APA, Washington 1987
  • Farnsworth D. The Farnsworth-Munsell 100-Hue and dichotomous test for color vision. J Opt Soc Am 1943; 33: 568–578
  • Verriest G, van Laethem J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-Hue test scores. Am J Ophthalmol 1982; 93: 635–642
  • Smith V C, Pokorny J, Pass A S. Color-axis determination on the Farnsworth-Munsell 100-Hue test. Am J Ophthalmol 1985; 100: 176–182
  • Kornhuber J, Bormann J, Hübers M, Rusche K, Riederer P. Effects of the i-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human post-mortem brain study. Eur J Pharmacol (Mol Pharmacol Sect) 1991; 206: 297–300
  • Contin M, Riva R, Martinelli P, Cortelli P, Albani F, Baruzzi A. Pharmacodynamic modeling of oral levodopa: clinical application in Parkinson's disease. Neurology 1993; 43: 367–373
  • Gasser T, Schwarz J, Arnold G, Trenkwalder C, Oertel W H. Apomor-phine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. Arch Neurol 1992; 49: 1131–1134
  • Colosimo C, Merello M, Albanese A. Clinical usefulness of apomorphine in movement disorders. Clin Neuro-pharmacol 1994; 17: 243–259
  • Dowling J E. Functional and pharmacological organization of the retina: Dopamine, interplexiform cells and neuromodulation. Vision and the Brain, B Cohen, I. Bodis-Wollner. Raven Press, New York 1990; 1–18
  • Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 1990; 31: 2473–2475
  • Herrera A J, Machado A, Cano J. Aging and monoamine turnover in the lateral geniculate nucleus and visual cortex of the rat. Neurochem Int 1993; 22: 531–539
  • Strange P G. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Mov Disord 1993; 8: 263–270
  • Ehinger B. Functional role of dopamine in the retina. Progress in Retina Research. Pergamon, Oxford 1983; 213–232
  • Zarbin M A, Wamsley J K, Palacios J M, Kuhar M J. Autoradiographic localization of high affinity GABA, benzodiazepine, dopaminergic, adrenergic and muscarinic cholinergic receptors in the rat, monkey and human retina. Brain Res 1986; 374: 75–92
  • Ruzicka E, Roth J, Spackova N, Mecir P, Jech R. Apomorphine induced cognitive changes in Parkinson's disease. J Neurol Neurosurg Psychiat 1994; 57: 998–1001
  • Imperato A, Scrocco M G, Bacchi S, Angelucci L. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur J Pharmacol 1990; 187: 555–556

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.